找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under

[復(fù)制鏈接]
樓主: POL
11#
發(fā)表于 2025-3-23 13:47:41 | 只看該作者
Radical Nephrectomy,, and a lymph node dissection, removing the paraaortic and paracaval nodal packets from the crus of the diaphragm superiorly to the aortic bifurcation inferiorly. Since that time, the technique of radical nephrectomy has undergone some modification, but the general principles outlined remain germane to today’s contemporary practice.
12#
發(fā)表于 2025-3-23 14:12:47 | 只看該作者
13#
發(fā)表于 2025-3-23 20:13:44 | 只看該作者
14#
發(fā)表于 2025-3-24 01:59:18 | 只看該作者
th renal cancer having localized or advanced disease are discussed. Surgical approaches for primary and metastatic tumors, symptom palliation, and systemic therapy for metastatic disease including immunotherapy and targeted approaches are discussed in detail..978-1-60761-469-2978-1-60327-149-3
15#
發(fā)表于 2025-3-24 05:41:00 | 只看該作者
https://doi.org/10.1007/978-3-642-88120-6s and experimental studies. Furthermore, pathologists could allocate any redundant tumor tissues not required for diagnosis to basic research programs. Pathologists, urologists, and other clinicians play equally important roles in the optimal handling and processing of renal cell carcinoma specimens.
16#
發(fā)表于 2025-3-24 09:32:14 | 只看該作者
17#
發(fā)表于 2025-3-24 14:14:06 | 只看該作者
Probleme der Sch?deldachplastikradiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
18#
發(fā)表于 2025-3-24 18:17:02 | 只看該作者
19#
發(fā)表于 2025-3-24 20:11:09 | 只看該作者
20#
發(fā)表于 2025-3-25 01:57:43 | 只看該作者
Adjuvant Therapy of Renal Cell Carcinoma,radiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 06:41
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
泽普县| 沂南县| 甘泉县| 北宁市| 宝鸡市| 延庆县| 射洪县| 兰考县| 大城县| 马山县| 化德县| 海门市| 山丹县| 神农架林区| 顺义区| 察隅县| 枣阳市| 黄浦区| 怀化市| 阳泉市| 张掖市| 霍州市| 池州市| 万源市| 阜城县| 平江县| 竹山县| 罗平县| 抚顺县| 新建县| 霍邱县| 广水市| 阳新县| 阿城市| 肃宁县| 黔西县| 玉环县| 景东| 株洲县| 扶绥县| 靖西县|